|Mr. Robert J. Coury||Exec. Chairman||1.83M||N/A||1961|
|Mr. Rajiv Malik||Pres & Exec. Director||4.47M||N/A||1961|
|Mr. Anthony Mauro||Pres of Developed Markets||2.55M||N/A||1973|
|Mr. Michael Goettler||CEO & Exec. Director||N/A||N/A||1968|
|Mr. Sanjeev Narula||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Sanjeev Kumar Sethi||Chief Operating Officer||N/A||N/A||1967|
|Mr. Paul B. Campbell||Chief Accounting Officer, Sr. VP & Corp. Controller||N/A||N/A||N/A|
|Mr. Ramkumar Rayapureddy||Chief Information Officer||N/A||N/A||N/A|
|Mr. Brian S. Roman||Global Gen. Counsel||N/A||N/A||N/A|
|Mr. David Bayles||Chief Compliance Officer||N/A||N/A||N/A|
Viatris Inc., a healthcare company, manufactures and distributes various medicines for patients in the United States and internationally. Its portfolio comprises approximately 1,400 approved molecules across a range of therapeutic areas, including non-communicable and infectious diseases; complex generic and branded medicines; a portfolio of biosimilars; and various over-the-counter consumer products, as well as active pharmaceutical ingredients. The company is headquartered in Canonsburg, Pennsylvania.
Viatris Inc.’s ISS Governance QualityScore as of December 3, 2020 is 9. The pillar scores are Audit: 6; Board: 6; Shareholder Rights: 6; Compensation: 10.